## **Core Concept**
Mucopolysaccharidosis (MPS) is a group of lysosomal storage disorders caused by the deficiency of enzymes required for the degradation of glycosaminoglycans (GAGs). These disorders result from the accumulation of GAGs within lysosomes due to enzymatic deficiencies. The underlying issue is related to lysosomal function and enzyme activity.

## **Why the Correct Answer is Right**
The correct answer, **lysosomal enzyme**, is right because mucopolysaccharidosis is primarily caused by deficiencies in lysosomal enzymes. These enzymes are crucial for breaking down glycosaminoglycans into smaller components that can be reused or excreted by the body. Without sufficient lysosomal enzyme activity, GAGs accumulate within lysosomes, leading to cellular dysfunction and the clinical manifestations of MPS.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While **plasma membrane** integrity and function are vital for cellular health, the primary issue in mucopolysaccharidosis is not directly related to the plasma membrane but to the lysosomal enzymes.
- **Option B:** **Peroxisomal enzyme** deficiencies lead to different types of storage diseases, known as peroxisomal disorders. These are distinct from lysosomal storage diseases like mucopolysaccharidosis.
- **Option D:** **Cytosolic enzyme** deficiencies can cause various metabolic disorders, but mucopolysaccharidosis specifically involves enzymes located within lysosomes.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that mucopolysaccharidoses are a subset of **lysosomal storage diseases**, which also include other conditions like Tay-Sachs disease and Pompe disease. These diseases often present with systemic symptoms and can affect multiple organ systems. Early diagnosis and management, including enzyme replacement therapy for some types, can significantly impact patient outcomes.

## **Correct Answer:** . **lysosomal enzyme**